4/A//SEC Filing
SAVIENT PHARMACEUTICALS INC 4/A
Accession 0001230295-06-000184
CIK 0000722104operating
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 4:11 PM ET
Size
8.2 KB
Accession
0001230295-06-000184
Insider Transaction Report
Form 4/AAmended
JAEGER STEPHEN O
Director
Transactions
- Award
Common Stock, $.01 par value per share
2006-06-30$5.25/sh+1,061$5,570→ 21,714 total - Award
Option to Purchase Common Stock, $.01 par value
2006-06-30$5.25/sh+6,286$33,002→ 6,286 totalExercise: $5.25From: 2007-06-30Exp: 2016-06-30→ Common Stock, $.01 par value per share (6,286 underlying)
Footnotes (3)
- [F1]These shares were granted pursuant to the Company's 2004 Incentive Plan, which provides for the grant to non-executive Chairperson of that number of shares of Common Stock having an aggregate fair market value on the last business day of each quarter up to $8,000.00, until he is no longer a non-executive Chairperson. On June 30, 2006 the fair market value of the Common Stock, based on the closing price, was $5.25.
- [F2]These options will become fully vested and immediately exercisable on 6/30/2007.
- [F3]Due to an administrative typo, the original timely filed Form 4 showed an incorrect amount in the 'Amount of Number of Shares' column.
Documents
Issuer
SAVIENT PHARMACEUTICALS INC
CIK 0000722104
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000722104
Filing Metadata
- Form type
- 4/A
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 4:11 PM ET
- Size
- 8.2 KB